Back to Grantham, Mayo, Van Otterloo & Co. LLC Grantham, Mayo, Van Otterloo & Co. LLC

PTGXPTGX
4 quarters

Position history for Grantham, Mayo, Van Otterloo & Co. LLCGrantham, Mayo, Van Otterloo & Co. LLC's holdings in PROTAGONIST THERAPEUTICS INC

Grantham, Mayo, Van Otterloo & Co. LLC previously held 0 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $0 as of 2020-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$461,000

Total Shares Change

-38,400

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2020-Q2
Latest
Exited
0
-100.0%
$00.0%$17.39
0
2020-Q1
Decreased
18,300
-8.5%
$129,0000.0%$7.17
0
2019-Q4
Decreased
20,000
-47.9%
$141,0000.0%$7.16
0
2019-Q3
New
38,400
-
$461,0000.0%$13.15
33

Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used